Introduction
In humans, early embryo development is a complex process that consists of sequential maturation events of the oocyte, fertilization and embryo growth (4-cell, 8-cell, morula and blastocyst) . Indeed, oocytes and spermatozoa are atypical, highly specialized cell types compared to somatic cells. Yet, after fertilization, a zygote is formed, the ultimate totipotent cell that can be considered to be the ultimate undifferentiated cell type, as it gives rise to all cell types and live offspring. Totipotency persists for the very first cell doublings, from the single cell and zygote to at least the 4-cell pre-embryo. Initiation of transcription in the newly-formed embryonic genome reportedly occurs at the 4-and 8-cell stage ( ). A few studies have documented key events that follow fertilization in humans such Braude et al., 1988 as decreases in abundance of individual mRNAs ( ), overall patterns of gene expression in individual human oocyte and Taylor et al., 2001 preimplantaion embryos stage ( ), and more generalizable transcription profiles of pooled morphologically normal Dobson et al., 2004 human oocytes and embryos ( ). These data provide fundamental resources for understanding the genetic network Zhang et al., 2009 controlling the early stages of human embryo development. At the morula stage, the human pre-embryo undergoes compaction, with the loss of the cellular distinction between the blastomeres. This is followed by the high expression of genes involved in tight intercellular junctions. Then, when the human embryo has reached the 35-to 65-cell stage, the trophoblast cells pump nutrients and water into the interior of the cell-sphere, forming a blastocyst, within which the inner cell mass (ICM) cells continue to proliferate. It is at the blastocyst 2 20 stage that ICM cells are harvested for the derivation of embryonic stem (ES) cells ( ; ). Reubinoff et al., 2000 Thomson et al., 1998 Pluripotent cells can be isolated, adapted and propagated indefinitely in an undifferentiated state as human embryonic stem cells in vitro (hESCs). hESCs are remarkable in their ability to generate virtually any cell type; hence they carry many hopes for cell therapy. Human mature MII oocytes, as well as hESCs, are able to achieve the feat of cell reprogramming towards pluripotency, either by somatic cell nuclear transfer or by cell fusion, respectively ( ; ; ; ). Cowan et al., 2005 Hochedlinger et al., 2004 Saito et al., 2008 Sung et al., 2006 Knowledge gathered from the field of ESCs was at the heart of the groundbreaking discovery that both mouse and human somatic cells can be reprogrammed into a pluripotent state by defined factors. The field of induced pluripotent stem cells (iPSCs) has marked a new era in stem cell research, and has also provided data pertinent to improving the understanding of pluripotency ( ; Takahashi et al., 2007 Yu et ) . Since totipotency and pluripotency are at the center of early embryonic development, comprehending their molecular al., 2007 mechanisms is crucial to our understanding of reproductive biology and to regenerative medicine.
DNA microarray technology is one of the most widely used and potentially revolutionary research tools derived from the human genome project (
). This technology provides a unique tool for the determination of gene expression at the level of Venter et al., 2001 messenger RNA (mRNA) on a genomic scale. Its capacity has opened new paths for biological investigation and generated a large number of applications ( ), including the analysis of the transcriptomic profiles from early embryo development and the Stoughton. 2005 identification of new prognostic biomarkers for use in the fertilization (IVF) program ( ; ). in vitro Hamatani et al., 2004a Assou et al., 2008 The application of microarray technology to the analysis of human oocyte and early embryo cleavage poses specific challenges associated with the picogram levels of mRNA in a single oocyte and embryo, the plasticity of the embryonic transcriptome, the scarcity of the material and ethical considerations.
In this review we analyzed data from published reports and include our own data to define the genomic profile during early embryonic development. Once the molecular signature is established, biomarkers can be identified on a large scale, validated and tested prior to clinical applications for embryo selection to improve single embryo transfer (SET) programs. Such a research workflow should provide an understanding of the molecular and cellular mechanisms of oocyte and embryo function, as well as important insights for the development of diagnostic tests for oocyte quality and embryo competence.
Methods
A search of English-language publications from 4 computerized databases (PubMed, EMBASE, Science Direct and Ingenta Connect) was undertaken. We built an expression compendium by combining U133 Plus 2.0 (Affymetrix, Santa Clara, USA) microarray data from the US National Center for Biotechnology Information, from the Gene Expression Omnibus (GEO) through the provisional accession numbers (the GSE7234, GSE7896, GSE11450, and GSE7896 series), and from 15 samples from our own laboratory (5 pooled oocytes, 2 embryos on day-3, and 8 hESC lines). This study received institutional review board (IRB) approval, as well as French authority: Agence de la Biom decine (ABM). The information gathered was analyzed through the GCOS 1.2 software (Affymetrix), using the default é analysis settings and global scaling as the first normalization method, with a trimmed mean target intensity value (TGT) for each array arbitrarily set to 100, in agreement with the MIAME recommendations ( ). Principle component analysis (PCA) was Brazma et al., 2001 performed using GeneSpring software to provide a global view of how the various sample groups were related. Hierarchical clustering ® was carried out with CLUSTER and TREEVIEW software ( ). To uncover functional biological networks, we imported Eisen et al., 1998 gene expression signatures into the Ingenuity Pathways Analysis (IPA) Software (Ingenuity Systems, Redwood City, CA, USA).
Results

Global analysis of the human oocytes gene expression profile
The human oocyte is equipped with an extraordinary biological competence. It can be fertilized and, at the same time, is able to reprogram the sperm chromatin, giving rise to totipotency and driving towards early embryonic development. However, the molecular mechanisms underlying oocyte competence are still largely unknown. Throughout follicle growth, the nuclear maturation of oocytes is arrested at meiotic prophase I. However, the cytoplasm progresses through a series of maturational stages, accumulating mRNAs and proteins that enable the oocyte to be fertilized and to progress through the first cleavage divisions until embryonic genes begin to be expressed. To improve the understanding of oocyte maturation and competence, microarray technology permits the assessment of changes of the global gene expression profiles in human and mouse oocytes (see ). Table I Gene expression of the oocyte during nuclear maturation Nuclear maturation is a fundamental developmental event that has been extensively studied for several years. However, the molecular mechanisms underlying this critical process remain incompletely understood. Many exciting biological questions surrounding this event persist. Differences in the global mRNA transcript profile have been reported between mature oocytes (metaphase II (MII)) and immature oocytes (germinal vesicle (GV) and metaphase I (MI)) in both mice and human ( ; ; Assou et al., 2006 Cui et al., 2007  ; modifications in the transcript profiles between GV and MI oocytes, while MII oocytes showed overexpression of more than 400 genes and a striking underexpression of more than 800 genes in comparison with less mature oocytes ( ). The major Assou et al., 2006 modifications of the transcript profile appear to occur during the final stage of oocyte maturation. Components of the metaphase-promoting factor, the anaphase-promoting complex, and a number of oocyte specific genes were overexpressed in MII oocyte ( ). Similarly, a global transcriptome comparison of GV-stage and MII-stage mouse oocytes revealed the expression of Assou et al., 2006 more than 12,000 genes by murine oocytes, more than 1,600 of which were upregulated in GV and 2,000 in MII oocytes (Cui et al., 2007 ). The authors reported a higher representation of genes associated with protein metabolism, the mitotic cell cycle, electron transport, fertilization, microtubule/cytoskeletal protein family, DNA replication, G protein-coupled receptors, and expression signalling in mature MII oocytes. The focus of our previously published study was to apply a microarray approach to identify new potential regulators and candidate genes involved in human oocyte maturation. In addition, ( ) observed that genes involved in the proteasome Assou et al., 2006 pathway were over-represented during human oocyte maturation ( ), suggesting an important role in oogenesis for this gene family. Fig. 1 This observation is of great interest in light of the recent findings on the role of the proteasome in transcription ( ). Szutorisz et al., 2006 The proteasome is known to interact with chromatin during multiple stages of transcription, through both proteolytic and non-proteolytic
activities (
). Proteolytic activities of the proteasome are important for promoting the exchange of transcription Collins and Tansey. 2006 factors on chromatin, and possibly for facilitating multiple rounds of transcription initiation. Non-proteolytic activities of the proteasome are important for transcriptional elongation checkpoint and histone modification ( the nucleus, consequently preventing apoptosis ( ).
reported that the apoptosis inhibitor protein Fabbro et al., 2004 Guillemin et al. (2009 undergoes dynamic sub-cellular redistribution during human oocyte maturation. Knockdown of mouse Bcl2l10 using RNA BCL2L10 interference (RNAi) in cultured oocytes resulted in maturation arrest at the MI stage accompanied by abnormal spindle and chromosome
organizations (
). These findings indicate that may play a role in oocyte maturation. Yoon et al., 2009 BCL2L10
Gene expression of oocytes according to female age
Oocyte quality is a main factor in human reproductive failure and has been strongly associated with advanced reproductive age. Recent studies have indicated differential gene expressions between younger and older oocytes in human ( ; Steuerwald et al., 2007 Grondahl et ) and mouse ( ; ). Age affects the expression of human oocyte genes in a variety of major al., Hamatani et al., 2004b Pan et al., 2008 functional categories, including cell cycle regulation, cytoskeletal structure, energy pathways, transcription control, and stress responses ( ). Recently, performed full-genome microarray analysis on individual oocytes of women Steuerwald et al., 2007 Grondahl et al. (2010 with advanced age in comparison with a younger patient. They observed a substantial difference between younger and older oocytes at the transcriptional level of genes involved in central biological functions, from establishment and organization of the meiotic spindle checkpoint, through protein metabolism and DNA repair to the regulation of meiotic division and cell cycle. In the mouse, gene profiles involved in oxidative stress, mitochondrial function, chromatin structure, DNA methylation and genome stability are altered with old age ( ). In addition, the expression profiling of young and old mouse oocytes revealed changes in the expression of Hamatani et al., 2004b several kinetochore components of the spindle assembly checkpoint (SAC); including protein kinases (e.g., , Aurora kinase) Bub1, BubR1 and , a critical activator of the Anaphase Promoting Complex ( ). Cdc20 Pan et al., 2008 Gene expression of oocytes under conditions in vitro Intrinsic oocyte developmental competence, as assessed by development up to the blastocyst stage, has been positively associated with the site of oocyte maturation ( ). The site of oocyte maturation has a profound effect on oocyte quality; oocytes matured Rizos et al., 2002 in vivo are of superior competence compared to those matured in vitro ( ). Microarray technologies were applied to Rizos et al., 2002 humans and to mice to identify the differences between development in vitro versus in vivo matured oocytes ( ; Jones et al., 2008 Pan et al., ;  ). compared the transcriptome of oocytes matured in vivo (with relatively high 2005 Patrizio. 2008 Jones et al. (2008) developmental competence) with the transcriptome of oocytes under in vitro maturations (IVM) conditions (with low developmental competence) and identified an over-abundance of a large number of genes in human oocytes matured in vitro compared with in vivo. This study suggested, that the increase in gene expression detected in vitro could be due to either a deregulation in gene transcription or the posttranscriptional modification of genes, causing an inadequate temporal utilization of transcripts which could be translated as a developmental incompetence of any embryos resulting from these oocytes. Similarly, indicated that the reduced Zheng et al. (2005) developmental competence of non-human primate oocytes under IVM was a result of a failure of these oocytes to undergo the normal pattern of transcript silencing.
elegantly differentiated the mRNA expression in human oocytes at different Wells and Patrizio (2008) maturational stages under IVM. They observed that high levels of mRNAs, proteins, substrates and nutrients are accumulated in the oocyte during maturation and are associated with oocyte developmental competence ( ; ). In addition, IVM seems Song et al., 2005 Watson. 2007 4 20 to alter the abundance of certain MII oocyte mRNAs compared with in vivo MII oocytes ( ; ). The Lee et al., 2008 Zheng et al., 2005 differences in gene expression detected may assist in the design of optimized protocols for ovarian stimulation and in further refining media formulations for IVM.
Gene expression of oocytes in PCOS patients
Polycystic ovary syndrome (PCOS) is a good model for studying the loss of oocyte quality. Studies comparing gene expression arrays in tissues from patients with PCOS compared with normal responders have reported similar pathways for differentially expressed genes in whole ovaries ( ; ) and oocytes ( ). identified 374 genes with Jansen et al., 2004 Oksjoki et al., 2005 Wood et al., 2007 Wood et al (2007 different mRNA transcript levels when analyzing morphologically indistinguishable oocytes from normal responders and PCOS patients ( ). Many of the genes found to be differentially expressed in PCOS are involved in signal transduction, transcription, Wood et al., 2007 DNA and RNA processing, and the cell cycle. Of these, 68 are involved in chromosome alignment and segregation; other genes contain putative androgen receptors ( ). These differences provide a partial explanation for the reduction of oocyte capacity Wood et al., 2007 observed in PCOS patients. Cumulus cells (CCs) play a major role in the control of oocyte metabolism, and therefore it is likely that dysfunction of these cells could play a role in PCOS.
Human oocyte-cumulus cells relationships
The oocyte is surrounded by several cell layers, CCs, which are tightly connected to each other and to the oocyte through gap junctions such as (Cx43) and ( ), that facilitate the bi-directional traffic between the oocyte and CCs ( GJA1 GJA4 Cx37 Tanghe et al., 2002 ). The oocytes create and control their microenvironment by promoting differentiation of the cumulus cell phenotype through secretion of paracrine signalling factors, such as growth and differentiation factor 9 ( and bone morphogenic protein-15 ( ), which are GDF9) BMP15 members of the transforming growth factor ( ) family ( ). Absence of these two oocyte-secreted factors has been β TGF β Eppig et al., 1997 shown to cause infertility ( ; ).
show increased cumulus production of hyaluronic acid Dong et al., 1996 Galloway et al., 2000 synthetase ( ), an enzyme responsible for the hyaluronic acid synthesis which is the major structural backbone of the cumulus HAS2 extracellular matrix ( ), as well as the proteoglycan , another important component of the cumulus matrix ( Elvin et al., 1999 versican come from several sources: they are synthesized directly by CCs under the control of endocrine and oocyte-derived factors, secreted by mural granulosa cells (GCs), or enter the follicle from blood plasma ( , ; ; ). Eppig. 1982 1991 Tanghe et al., 2002 Vanderhyden et al., 2003 In addition, CCs and oocytes have different metabolic needs. Oocytes themselves are unable to synthesize cholesterol and poorly metabolize glucose for energy production. Inversely, the CCs metabolize alternative substrates, such as cholesterol and glucose, which are essential for the development and function of oocyte ( ). The exact nature and diversity of oocyte-CC signalling Eppig et al. 2005 molecules are complex and dynamic. Errors in the regulatory cumulus-oocyte complex (COC) may result in the production of oocytes unable to undergo embryo and pregnancy outcomes. The study of the CC gene expression profile offers the opportunity by a non-invasive method, to predict oocyte competence, because bidirectional communication between the CC and the oocyte are necessary for acquisition of this competence.
Global analysis of human embryo gene expression profile
Embryo survival requires that the oocyte be sufficiently equipped with stored maternal products and that embryonic gene expression Table I embryos showed characteristic patterns of maternal RNA depletion and revealed that embryonic genome activation (EGA) happens in two phases: the first phase is zygotic genome activation (ZGA), the second mid-preimplantation gene activation (MGA), which precedes the dynamic morphological and functional changes from the morula to the blastocyst stage ( ). Two major groups of gene Hamatani et al., 2006 activity can be defined: firstly in oocytes and first early cleavage stages and the second consisting of 4-cell to blastocyst stages, which correlates with the transition from maternal to zygotic expression. Several transcripts of molecules involved in or signalling WNT BMP pathways were identified in the embryonic transcriptome, indicating that these critical regulators of cell fate and patterning are conserved and functional at these stages of pre-implantation development.
reported the global patterns of gene expression in Dobson et al. (2004) human embryos on day 2 and 3 (n 8) by using DNA microarray analysis. This study revealed that the first few days of oocyte maturation = and embryo development were characterized by a significant decrease in transcript levels, suggesting that decay of RNAs associated with gamete identity is integral to embryo development ( ). Furthermore, this study revealed that developmental arrest and Dobson et al., 2004 activation of the embryonic genome are unrelated events.
used reverse transcription and real-time fluorescent PCR to Wells et al. (2005) quantify the expression patterns of nine known genes implicated in DNA damage and cell division (  ,  ,  ,  ,  BRCA1 BRCA2 ATM TP53 RB1 ,  ,  , , and ) at the early stages of human embryonic development. The data suggest that embryos with MAD2 BUB1 APC beta-Actin patterns of gene expression appropriate for their developmental stage may have superior viability to those displaying atypical gene activities ( ). used a cDNA microarray containing 9,600 transcripts to investigate 631 differently Wells et al., 2005 Li et al. (2006 expressed genes in oocytes, as well as the 4-cell and 8-cell human embryonic stages. Numerous genes were found to be expressed at a value double that of the median value of all genes expressed; 184 genes in oocytes, 29 in 4-cell embryos, and 65 genes in 8-cell embryos.
These results indicate that the expression of some zygotic genes had already occurred at the 4-cell embryonic stage ( ). In Li et al., 2006 addition, observed global gene expression changes during the hatching of mouse blastocysts, an essential process for Chen et al. (2005) implantation. This study observed that there were 85 genes which were upregulated in blastocysts at the hatching stage. These genes included cell adhesion molecules, epigenetic regulators, stress response regulators, and immunoresponse regulators ( The molecular mechanism of early embryonic development is still unclear. To identify genes that are involved in early embryonic development, we have conducted an analysis related to the expression profiles of five pooled oocytes, two embryos on day-3 and eight human embryonic stem cell (hESC) lines. In order to ascertain whether there is a specific molecular signature corresponding to each stage of early embryonic development, we performed principal component analysis (PCA) and hierarchical clustering ( ). All of the Figure 2 oocyte, embryo and hESC samples clustered as homogeneous groups ( ) in agreement with the robustness of the Affymetrix Figure 2A 
microarrays (
). Hierarchical clustering on 10,000 genes delineated five major clusters of genes ( ). The Irizarry et al., 2005 Figure 2B
hierarchical clustering dendrogram showed that hESCs are distantly related to oocytes and embryos on day-3 ( ), revealing the Figure 2C distinctive patterns of maternal RNA degradation and embryonic gene activation, which contribute to the dramatic morphological changes during early embryonic development. We identified genes whose expression gradually increased or decreased during early embryonic development ( ). Taken together, these results seem to indicate that early embryonic development, particularly totipotent cells Figure repair of DNA, as well as methylation of DNA, is crucial in gametogenesis, fertilization and pregnancy. Recently, DNA repair gene expression was investigated in human oocytes and blastocysts to identify the pathways involved at these stages and to detect potential differences in DNA repair mechanisms of pre-and post-embryonic genome activation ( ). Large numbers of repair Jaroudi et al., 2009 genes were detected indicating that all DNA repair pathways are potentially functional in human oocytes and blastocysts. Expression levels of DNA repair genes at the pre-and post-EGA transcriptional level suggest differences in DNA repair mechanisms at these developmental stages ( ). Jaroudi et al., 2009 Epigenetic regulation of human early embryonic development Epigenetics refers to a collection of mechanisms that can cause a change in the phenotype of a cell without altering its DNA sequence ( ). Early embryonic development is regulated epigenetically. During the development process, the epigenetic Goldberg et al., 2007 signature changes as the cell enters fertilization and/or differentiation. DNA methylation is an important epigenetic event, regulating gene expression and chromatin structure in any developmental processes including gene imprinting and embryogenesis ( and its exceptional preference for hemimethylated DNA indicates its role in the maintenance of methylated status during DNA replication.
Genetic studies have suggested that may play a role in the methylation of repeat elements in growing oocytes ( DNMT1 Gaudet et al., 2004 ). Our genes expression data indicate that the mRNA was overexpressed in mature MII oocytes and decreased progressively in DNMT1 embryos on day-3 and in hESCs ( ), revealing that the oocyte-specific transcript is expressed in human oogenesis and Figure 3B DNMT1
persists in embryos at day-3. transcripts were detected in mature MII oocytes and hESCs ( ), and the DNMT3B Assou et al., 2009 expression of was enriched in undifferentiated hESCs ( ; ; ), DNMT3A Assou et al., 2007 Huntriss et al., 2004 Richards et al., 2004 indicating that the family methyltransferases are candidate epigenetic regulators during preimplantation development. Both DNMT3 As imprinting is closely related to embryogenesis, we analyzed the expression of imprinted genes in oocytes, embryos on day-3 and hESCs. We looked at the expression of forty imprinted human genes ( ) in our data (the list of imprinted genes is Morison et al., 2001 available at ). The analysis of the expression levels of these imprinted genes compared with their expression http://www.otago.ac.nz/IGC levels in mature MII oocytes, embryos on day-3, and hESCs reveals their reprogramming time points in humans. Several imprinted genes (see ) were expressed to high levels in the oocytes, embryos, and hESCs. The study of the methylome and the epigenome is Table II important because minor defects can lead to serious human diseases. Indeed, several syndromes are associated with imprinting defects during preimplantation development ( ; ). Beyond transcription and epigenetics, the discovery van der Maarel. 2008 Yamazawa et al., 2008 of hundreds of microRNAs (miRNAs) has defined yet another level of mRNA regulation that could have a major impact on defining the mechanisms controlling early embryonic development ( ; ). These short mRNAs have the ability to Blakaj et al., 2008 Kedde et al., 2008 target and regulate the translation and stability of target mRNAs, and thus are likely to have profound effects on embryonic gene expression patterns.
Expression of known components of two pathways in human early embryo development
Known components of two signalling pathways involved in human early embryonic development, (i) the signalling pathway and WNT (ii) the superfamily pathway, have been observed. TGF-β
WNT signalling
The gene family consists of numerous conserved glycoproteins that regulate pattern formation during embryogenesis in a wide WNT variety of tissues ( ). Limited data is available about the role of the pathway in the reproduction process. It has Morkel et al., 2003 WNT been shown that this pathway is operational during human and mouse pre-implantation development stages ( ). Adjaye et al., 1999 Furthermore, it has also been reported that activation of the canonical pathway is sufficient to maintain self-renewal of both human WNT and mouse ESCs ( we observed the expression of most members of the superfamily in human oocytes, embryos on day-3, and hESCs ( ). TGF-β Figure 3C However, some components of the pathway, such as / , are absent in oocytes but present in both embryos on TGF-β ACTIVIN INHIBIN day-3 and hESCs, whereas is present only in hESCs. It was recently shown that human iPSCs rely on NODAL ACTIVIN/NODAL signalling to control expression and thereby maintain pluripotency ( ). The transcription factors and NANOG Vallier et al., 2009 SMAD4 are significantly overexpressed in hESCs but are underexpressed in both oocytes and embryos on day-3. In addition, it was shown SMAD7 that mouse embryos deficient in display defective epiblast proliferation and delayed outgrowth of the ICM ( ). SMAD4 Sirard et al., 1998 Expression of the signalling receptors for in human oocytes and embryo at blastocysts stage, suggests a role for in early TGF-β TGF-β pre-implantation development.
The expression program of human embryonic stem cells
hESCs do not exist in nature but are derived from the inner cell mass (ICM) of the human blastocyst ( ) and are Thomson et al., 1998 considered equivalent to ICM cells, having captured the phenotype of a cell type that exists only transiently . investigating fundamental aspects of the early embryo development and the pluripotency. Numerous genomic studies have used microarray techniques to capture a detailed view of ESC gene expression ( ; ; ; Abeyta et al., 2004 Assou et al., 2007 Beqqali et al., 2006 ; ; ) . These transcriptome data can generate Bhattacharya et al., 2004 Cowan et al., 2005 Forsyth et al., 2008 Golan-Mashiach et al., 2005 molecular signatures of ESCs that define the individual components, and the pathways, that regulate pluripotency and maintain the undifferentiated state. We performed a meta-analysis of 38 papers on the topic ( ). We determined that 1,076 genes were Assou et al., 2007 found to be upregulated in hESCs by at least three studies when compared to differentiated cell types. In fact, only a single gene, , OCT3/4 was found to be in common to all 38 lists of hESC-specific genes. Our analysis shows that gene expression analyses are sensitive to experimental conditions, therefore requiring extreme caution during data interpretation. A cross-comparison of the gene lists generated by these efforts shows that , , , , , and are commonly expressed in the majority of hESCs ( OCT3/4 NANOG SOX2 DNMT3B LIN28 CD24 Sato et al., 2003 Wei et al., 2005 Wei et al. (2005 gene expression profiles between hESC and mESC, and showed that was overexpressed in mice, but not in humans; was LIFR FGF2 overexpressed in humans, while was abundant in mice. Epiblast derived mouse ESCs also maintain self-renewal by the dependence FGF4 on FGF2, hence activated FGF signalling ( ; ). The accumulating ESC transcriptome data is now being Brons et al., 2007 Tesar et al., 2007 aimed at identifying molecular markers that will be useful for quality control of ESCs for clinical applications.
Common molecular signatures between human metaphase II oocytes and ICM
ESCs and mature MII oocytes are able to reprogram the nuclei of fully differentiated human somatic cells and render these cells pluripotent ( ; ). Through the comparative analysis of the transcriptome of such cells, it may be Cowan et al., 2005 Rideout et al., 2001 possible to achieve a better understanding of the mechanism of nuclear reprogramming, the molecular events which occur during the first week of human embryo development, and the identification of the genes involved in pluripotency initiation ( ; Kocabas et al., 2006 Zhang ;  ). compared the transcriptome of human MII oocytes and hESCs with a reference et al., 2007 Assou et al., 2009 Kocabas et al. (2006 sample consisting of a mixture of total RNA from different normal somatic cells. In this study, the authors identified 1,626 transcripts that were significantly upregulated in the hESs relative to somatic cells. Intersection of these 1,626 transcripts enriched in hESCs with the 5,331 transcripts enriched in human MII oocytes, identified 388 common genes that are hypothesized to play an important role in oocyte reprogramming and early events associated with human early embryo development ( ). obtained a Kocabas et al., 2006 Zhang et al. (2007 large amount of information on gene expression in human oocytes at GV stage as compared with hESCs. In total, 1,629 genes were upregulated in GV oocytes when compared with hESCs and human foreskin fibroblasts (hFIBs). This list of genes, including , MATER , , , some imprinted genes, and some components of four signalling pathways such as , , ZAR1 NPM2 FIGLA MOS-MPF NOTCH WNT and ( ), may provide good candidate genes for understanding the oocyte maturation and the early embryonic TGF-beta Zhang et al., 2007 development. On the other hand, compared the gene expression profiles of mature MII oocytes with hESCs, and then Assou et al. (2009) both to somatic tissues. There was a common oocyte/hESC gene expression profile, which included genes associated with pluripotency, such as and , and a large chromatin remodeling network ( , , ,
TDGF1 TOP2A DNMT3B JARID2 SMARCA5 CBX1 CBX5
Interestingly, a large set of genes was also found to code for proteins involved in the ubiquitination and proteasome pathway (Assou et al., ). This list provides reliable candidate genes for future studies on molecular mechanisms of pluripotency and nuclear reprograming. 2009
The zinc finger motif is a DNA binding domain dependent on a zinc ion frequently found in transcription factors. In seeking to identify genes encoding zinc finger domain proteins expressed in both mature MII oocytes and hESCs, we observed that the distribution of genes encoding these proteins on the genome is not random: they are significantly enriched in chromosomes 19 and 20 in mature MII oocytes, and in 16 and 17 in hESCs ( ). As can be seen in , seven zinc finger proteins were common to mature MII Assou et al., 2009 Figure 4 oocytes and hESCs, three were found in oocytes only (e.g. , , ), and three in hESCs only (e.g. , ZNF528 ZNF468 ZNF313 ZNF268 , ).
ZNF232 ZNF423
Human early embryo development transcriptome data visualization through an internet interface ( ) is a freely accessible web site dedicated to the visualization of large, publicly Amazonia ! http://www.amazonia.transcriptome.eu available human transcriptome data, including data on stem cells, human embryo and germinal cells, for facilitating the free exchange of information on genomics. Data is visualized as expression bar plots with a color code enabling the recognition of cell type (Assou et al., ; ). Genes are accessed either by keywords or through lists. Most interestingly, when data is obtained using 2007 Le Carrour et al., 2010 the same platform format, sample labeling, and data normalization, it is possible to combine different experiments in a single virtual experiment.
generate bar plots that combine expression in oocytes, embryos and hESCs with more than 200 germinal and Amazonia ! somatic tissues.
Omics: tools for the identification of reliable biomarkers for oocyte and embryo selection
Since the birth of Louise Brown, the first baby conceived by IVF in the UK in 1978, more than 2 million children in the world have been born as a result of assisted reproductive technology (ART). Since then, these techniques have advanced considerably. ART protocols continue to evolve with the aim of achieving higher pregnancy rates, reducing multiple pregnancies and obtaining healthier babies.
However, despite the incontestable advances, the pregnancy rate is still relatively low and has not increased significantly in the last decade (
). The selection of embryos with higher implantation potential is one of the major challenges in ART. Initially, Andersen et al., 2007 multiple embryo transfer was used to maximize pregnancy rates. However, improved embryo quality and rising multiple pregnancy rates has resulted in the decrease in number of embryos for replacement. Therefore, selection of the best embryo has become crucial,
particularly with elective SET being strongly recommended. There is therefore a need to develop new objective approaches for embryo selection. The classical methods to select healthy embryos under IVF and ICSI conditions are based on morphological criteria such as early embryonic cleavage, the number and size of blastomeres, fragmentation degree, and the presence of multi-nucleation at the 4-or 8-cell stages ( ). However, most studies suggest, that embryos with proper morphological appearance alone are not Fenwick et al., 2002 sufficient to predict a successful implantation. Beyond the criteria of embryo selection, defining oocyte quality remains one of the most difficult challenges ( ). Many morphologically normal embryos do not achieve implantation or spontaneously abort Wang, Q. et al., 2007 during pregnancy. Considering the limitation of morphologic evaluation and cytogenetic screening methods, there is now a movement towards more sophisticated, high-performance technologies and the emerging omics science, such as genomics, transcriptomics,
proteomics, and metabolomics ( ). These approaches may contribute to the design of a non-invasive viability assay to assist in Hillier. 2008 the embryos selection in IVF or ICSI programs. It is necessary to distinguish the invasive approaches, which are based on direct analysis of the oocyte and embryo, from non-invasive approaches ( ). Can omics approaches help shape the future of ART? Figure 5 
Transcriptomic approach
Several investigations using reverse transcription followed by real-time PCR have found that specific genes display alterations in activity apparently related to oocyte or embryo quality ( ; ). Despite the accuracy and sensitivity of Dode et al., 2006 Fair et al., 2004 real-time PCR, it is still limited by the restricted number of genes that can be assessed per single oocyte or embryo. Microarray technology permits the simultaneous analysis of tens of thousands of genes, and provides greater hope for the identification of new biomarkers.
Transcriptomics represent a valuable approach to biomarkers development. Both technical and statistical advances are currently facilitating the integration of this approach to IVF programs. The transcriptomic approach has been used experimentally in humans on throphoblastic biopsies of blastocysts ( ). Analysis of the transcriptome of aneuploid and normal oocytes, as determined by comparative Jones et al., 2008a genomic hybridization (CGH) analysis of the corresponding polar bodies, has identified several differentially expressed genes with roles in chromosome segregation during meiosis, including genes affecting cell cycle checkpoints, spindle dynamics, and chromosomal movement (  ;  ;  ; ). An indirect and attractive approach Fragouli et al., 2006b Fragouli et al., 2006a Fragouli et al., 2009 Gutierrez-Mateo et al., 2004 for predicting embryo and pregnancy outcomes has been recently reported by using transcriptomic data of CCs gene expression (Assou et ). The CCs are abundant and easily accessible, which makes them an ideal material to use for the potential assessment of oocyte al., 2008 and embryo quality. Data concerning biomarker expression in these cells should yield more precise information, improving the embryologists capacity to select competent embryos either for fresh replacement or for embryo freezing. By studying genes expression ' profile of CCs or GCs using microarrays or reverse transcription-polymerase chain reaction (RT-PCR) and quantitative RT-PCR some studies have identified candidate biomarkers for (i) oocyte quality and competence ( ; ; Zhang et al., 2005 Cillo et al., 2007  ), (ii) early embryo development ( ; ; 2008 Adriaenssens et al., 2010 Anderson et al., 2009 McKenzie et al., 2004 ) and (iii) embryo quality and pregnancy outcome ( ; ) ( ). reported 2008 Assou et al., 2008 Hamel et al., 2010 Table III Zhang et al. (2005 that the expression of pentraxin-3 ( ) in CCs was positively correlated with oocyte competence. was initially studied for its PTX3 PTX3
possible role in inflammatory reaction processes ( ). Fertilization is very low in knoukout mice ( Gewurz et al., 1995 in vivo PTX3 Varani et ). reported that a number of genes including prostaglandin-endoperoxide syntase-2 ( ) and al., Feuerstein et al (2007 PTGS2 steroidogenic acute regulatory protein ( ) were also negatively associated with oocyte competence. In addition, the expression of STAR gremlin 1 ( ) is also indicative of embryo quality ( ; ; , GREM1 McKenzie et al., 2004 Cillo et al., 2007 Anderson et al., 2009 production, and regulates some of the earliest processes in embryonic development. Other studies associated the gene expression NFIB profile in follicular cells (CCs or GCs) with pregnancy ( ). They found that variation of , a transferase enzyme Hamel et al., 2010 PGK1 involved in the process of glycolysis and regulation of G-protein signalling 2 ( ) in follicular cells are likely candidate genes that RGS2 could have a utility in the prediction of pregnancy. All these studies provide supporting evidence to the concept that CCs are a promising source of reliable biomarkers for predicting oocyte quality and/or embryo and/or pregnancy outcome ( ). These efforts will Table III ultimately lead to improved efficiency outcomes of ART.
Proteomic approach 9 20
Proteomics describes changes in the expression of proteins translated from a single genome. The human proteome, estimated at over a million proteins, is highly diverse and dynamic. The analysis of the protein composition of the embryos poses a particular challenge because of the low concentration and wide dynamic range of the population of molecules which need to be analyzed; unlike mRNA, proteins cannot be amplified for analysis. Recent advances in mass spectrometry have led to the development of methods sensitive enough to allow the examination of the secretome of single oocytes or embryos. The secretome has been defined as the subset of secreted or consumed proteins that can be found in the environment where the oocyte or embryo grows. It is now possible to obtain comprehensive protein profiles from limited amounts of complex biological fluids including IVF spent culture mediums. The secretome of an individual human embryo has been previously analyzed by surface-enhanced laser desorption and ionization time-of-flight (SELDI-TOF) mass spectrometry (MS) technology, and distinctive secretome signatures were observed at each embryonic developmental stage from fertilization to the blastocyst stage ( ; ). However, no clear biomarkers of embryo viability Katz-Jaffe et al., 2006 Katz-Jaffe et al., 2009 and implantation have yet been reported. compared blastocyst conditioned media with control medium using Dominguez et al. (2010) protein microarrays, thus revealing increased expression of interleukin 10 ( ) and soluble tumor necrosis factor ( ) receptor 1 ( IL-10 TNF ) and decreased expression of stem cell factor ( ) and chemokine ligand 13 ( ) ( ). Other TNFR1 SCF CXCL13 Dominguez et al., 2010 studies have reported a link between the level of cytokines in human follicular fluid (hFF) and the implantation potential of the embryo derived from the oocyte of this follicle. Using a bead-based multiplex sandwich immunoassay (Luminex), Ledee et al. (2008) demonstrated that only granulocyte colony-stimulating factors ( ) measured in individual hFF samples together with 26 other G-CSF cytokines was particularly elevated in the hFF corresponding to the embryos with highest implantation potential ( ). In Ledee et al., 2008 addition, significantly higher levels of interleukin 10 ( ) and interferon ( ) were found in hFF from oocytes that generated early IL10 IFN-γ cleavage embryos. However, Luminex technology is complex and expensive. Further studies will help to confirm the advantageous applications of proteomics testing in the field of IVF.
Metabolomic approach
Metabolomics aims at the comprehensive and quantitative analysis of metabolites in biological samples. This approach is presently being applied to human embryos ( ; , ) and oocytes ( ). Because of the chemical Botros et al., 2008 Seli et al., 2008 Singh et al., 2007 diversity of cellular metabolites, no single analytical platform can measure the metabolome in a cell. This is due to the absence of methods to amplify metabolites, the labile nature of many metabolites, and their chemical heterogeneity and complexity. Thus, measuring the metabolome is a considerable analytical challenge. Rapid technological advances in MS and nuclear magnetic resonance (NMR) have enabled the simultaneous detection of a wide range of small molecules. Recently, the development of a screening technology using Raman and near infrared (NIR) spectroscopy were used to detect biomarkers in culture medium with algorithms generated for positive, as compared to negative, IVF outcomes ( ; ). NIR analysis is not typically used for target metabolite Scott et al., 2008 Seli et al., 2007 identification, but is used for overall spectral profile comparisons. Recent studies using a SET program on days-2 and -3 showed higher mean viability scores for embryos that resulted in a pregnancy with fetal heart activity, compared with those without ( ; Seli et al., 2008 ). They showed that metabolomic profiling of culture media from embryos was independent of morphology. Vergouw et al., 2008 Large-scale, prospective studies are necessary to relate the metabolic profile of medium to the developmental potential of human oocytes and embryos. In addition, the ideal metabolomic profile should be confirmed by several independent platforms.
Conclusion
This review highlights the recent advances in elucidating the molecular complexity in early embryonic development. The knowledge of the global pattern of gene expression is important for understanding critical regulatory pathways involved in the crucial steps of early embryonic development. Certain gene expression profiles help to unravel the mystery of these developmental stages. Further understanding of the biological role of these genes may expand our knowledge of the oocyte maturation, fertilization, chromatin remodeling, totipotency, pluripotency, and early morphogenesis steps. The practical implications of compiling gene expression information on human oocytes and embryos would be enormous since it could potentially help us to understand and solve problems related to infertility.
In recent years, the emergence of new technologies Omics such as microarrays have already started to be used in the IVF/ICSI ' ' program. The use of microarray technology in the analysis of early embryonic development poses specific challenges associated with the picogram levels of mRNA in a single cell/embryo. Another challenge for applying microarrays to early embryonic development is the high degree of expression plasticity seen in early stage embryos.
The ideal DNA microarrays would potentially give rise to diagnostics for assessing human embryo quality in IVF program. The application of transcriptomic, proteomic and metabolomic approaches have greatly broadened our understanding of early human development. The challenge now is to correlate gene/protein/metabolite function and regulation to specific events in early embryonic development. These tools may ultimately lead to non-invasive tests for oocyte or embryo quality revealing previously hidden information concerning both oocyte and embryonic developmental competence. Once fully validated, these new approaches are expected to improve oocyte and embryo selection, leading to increased implantation rates and higher success in elective SET. A multitude of advantages may ensue from the use of a rapid, non-invasive and reliable technology as an adjunct to embryo assessment for clinical applications. An improved understanding of embryo viability should help to identify the healthy embryos that will most likely result in pregnancy and allow more accurate decisions in selecting the best embryo for the SET program.
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Figure 1
Upregulation of proteasome genes during oocyte maturation. Histograms show signal values of six proteasome genes (PSMA2, PSMA5, and ) in each stage of oocyte maturation. Gene expression is measured by pan-genomic HG-U133 Plus PSMD2, PSMD9, PSMD11 PSMG1 2.0 Affymetrix oligonucleotides microarrays, and the signal intensity for each gene is shown on the Y-axis as arbitrary units determined by the GCOS 1.2 software (Affymetrix). GV; germinal vesicle; MI, metaphase I; MII, metaphase II. replicate samples of the hESC group self-cluster into one branch. Both oocyte and embryo samples self-cluster into another branch (dotted box) that further divides into two major sub-branches and into which all the replicates from oocytes and embryos self-cluster.
Figure 3
Expression of selected genes in human oocytes, and embryos on day-3 and hESCs. Figure show signal values of 18 genes that are gradually increased (A) or decreased (B) during early embryonic development. (C) Characterization of signalling pathway during early TGF-β embryonic development. Genes shown in red are upregulated in human oocytes or in embryos on day-3 or in hESCs. Examples of genes overexpressed (red) in each stage are indicated in boxes.
Figure 4
Chromosomal distribution of genes encoding zinc finger domain proteins were expressed significantly differently in human mature oocytes (light violet) as compared to hESCs (light pink) as well as to those commonly expressed in mature human oocytes and hESCs (light yellow).
The selected genes were retrieved in lists previously published in ( ). Assou et al., 2009 Page / 16 20
Figure 5
Different direct or indirect approaches suggested for oocyte or embryo selection (transcriptomic, proteomic and metabolomic approaches).
